Tscan Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Tscan Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tscan Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Tscan Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $1.2M | 853k | 1.45 |
| 2024-12-31 | $1.3M | 413k | 3.04 |
| 2024-09-30 | $1.5M | 299k | 4.98 |
| 2024-06-30 | $1.4M | 242k | 5.85 |
| 2024-03-31 | $1.8M | 224k | 7.94 |
| 2023-12-31 | $1.4M | 235k | 5.83 |
| 2023-09-30 | $664k | 259k | 2.56 |
| 2023-06-30 | $271k | 109k | 2.50 |
| 2022-12-31 | $65k | 42k | 1.55 |
| 2022-06-30 | $180k | 57k | 3.15 |
| 2022-03-31 | $134k | 39k | 3.42 |